Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Harvard University
Pharma
Novo's Ozempic, Wegovy linked to eye problem: study
A Harvard study has associated semaglutide with nonarteritic anterior ischemic optic neuropathy. But the analysis has several limitations.
Angus Liu
Jul 8, 2024 10:49am
Harvard offshoot 64x Bio nets $55M in series A funding
Jan 19, 2022 10:48am
BMS, Eisai and Lundbeck ally to crack blood-brain barrier
Jun 14, 2021 8:05am
Sanofi taps Harvard spinout for oral nanobody delivery work
Feb 16, 2021 7:35pm
Harvard-GIRH, GSK-Clover, Vir-WuXi and more—FiercePharmaAsia
Feb 28, 2020 10:35am
Cell and viral vector manufacturing facility backed by Harvard
Nov 25, 2019 9:50am
